Adam Klocperk1, Lenka Petruzelkova2, Marketa Pavlikova3, Michal Rataj4, Jana Kayserova4, Stepanka Pruhova2, Stanislava Kolouskova2, Jana Sklenarova2, Zuzana Parackova4, Anna Sediva4, Zdenek Sumnik2. 1. Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic. adam.klocperk@fnmotol.cz. 2. Department of Pediatrics, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic. 3. Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic. 4. Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
Abstract
AIMS: The development of the immune phenotype in patients with type 1 diabetes (T1D) during the first year following disease onset remains poorly described, and studies analysing the longitudinal development of a complex set of immunological and metabolic parameters are missing. Thus, we aim to provide such complex view in a cohort of 38 children with new onset T1D who were prospectively followed for 1 year. METHODS: All subjects were tested for a set of immunological parameters (complete blood count; serum immunoglobulins; and T, B and dendritic cells), HbA1c and daily insulin dose at baseline and at 6 and 12 months after T1D diagnosis. A mixed meal tolerance test was administered to each of the subjects 12 months after diagnosis, and the C-peptide area under the curve (AUC) was noted and was then tested for association with all immunological parameters. RESULTS: A gradual decrease in leukocytes (adjusted p = 0.0012) was reflected in a significant decrease in neutrophils (adjusted p = 0.0061) over the post-onset period, whereas Tregs (adjusted p = 0.0205) and originally low pDCs (adjusted p < 0.0001) increased. The expression of the receptor for BAFF (BAFFR) on B lymphocytes (adjusted p = 0.0127) markedly increased after onset. No immunological parameters were associated with C-peptide AUC; however, we observed a linear increase in C-peptide AUC with the age of the patients (p < 0.0001). CONCLUSIONS: Our study documents substantial changes in the innate and adaptive immune system over the first year after disease diagnosis but shows no association between immunological parameters and residual beta-cell activity. The age of patients remains the best predictor of C-peptide AUC, whereas the role of the immune system remains unresolved.
AIMS: The development of the immune phenotype in patients with type 1 diabetes (T1D) during the first year following disease onset remains poorly described, and studies analysing the longitudinal development of a complex set of immunological and metabolic parameters are missing. Thus, we aim to provide such complex view in a cohort of 38 children with new onset T1D who were prospectively followed for 1 year. METHODS: All subjects were tested for a set of immunological parameters (complete blood count; serum immunoglobulins; and T, B and dendritic cells), HbA1c and daily insulin dose at baseline and at 6 and 12 months after T1D diagnosis. A mixed meal tolerance test was administered to each of the subjects 12 months after diagnosis, and the C-peptide area under the curve (AUC) was noted and was then tested for association with all immunological parameters. RESULTS: A gradual decrease in leukocytes (adjusted p = 0.0012) was reflected in a significant decrease in neutrophils (adjusted p = 0.0061) over the post-onset period, whereas Tregs (adjusted p = 0.0205) and originally low pDCs (adjusted p < 0.0001) increased. The expression of the receptor for BAFF (BAFFR) on B lymphocytes (adjusted p = 0.0127) markedly increased after onset. No immunological parameters were associated with C-peptide AUC; however, we observed a linear increase in C-peptide AUC with the age of the patients (p < 0.0001). CONCLUSIONS: Our study documents substantial changes in the innate and adaptive immune system over the first year after disease diagnosis but shows no association between immunological parameters and residual beta-cell activity. The age of patients remains the best predictor of C-peptide AUC, whereas the role of the immune system remains unresolved.
Entities:
Keywords:
C-peptide; Immune system; Partial remission; Type 1 diabetes
Authors: Alessandra Petrelli; Sarah K Popp; Riho Fukuda; Christopher R Parish; Emanuele Bosi; Charmaine J Simeonovic Journal: Front Immunol Date: 2022-07-06 Impact factor: 8.786
Authors: Silvia Rodriguez-Fernandez; Marta Murillo; Adrian Villalba; David Perna-Barrull; Mary Cano-Sarabia; Laia Gomez-Muñoz; Eva Aguilera; Daniel Maspoch; Federico Vazquez; Joan Bel; Marta Vives-Pi Journal: Front Immunol Date: 2019-11-28 Impact factor: 7.561
Authors: Laia Gomez-Muñoz; David Perna-Barrull; Josep M Caroz-Armayones; Marta Murillo; Silvia Rodriguez-Fernandez; Aina Valls; Federico Vazquez; Jacobo Perez; Raquel Corripio; Luis Castaño; Joan Bel; Marta Vives-Pi Journal: Front Immunol Date: 2022-02-23 Impact factor: 7.561
Authors: John F Cipollo; Ian A York; Irina V Alymova; Lisa M Parsons; Nedzad Music; Ram P Kamal; Wen-Pin Tzeng; Cynthia S Goldsmith; Joseph N Contessa; Kevan L Hartshorn; Jason R Wilson; Hui Zeng; Shane Gansebom Journal: mBio Date: 2022-03-14 Impact factor: 7.786
Authors: Natasha Qaisar; Adediwura Arowosegbe; Alan G Derr; Alper Kucukural; Basanthi Satish; Riccardo Racicot; Zhiru Guo; Melanie I Trombly; Jennifer P Wang Journal: Immunohorizons Date: 2021-10-26
Authors: Adam Klocperk; Jana Vcelakova; Petra Vrabcova; Irena Zentsova; Lenka Petruzelkova; Zdenek Sumnik; Stepanka Pruhova; Anna Sediva; Zuzana Parackova Journal: Front Immunol Date: 2021-07-07 Impact factor: 7.561